カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の血漿分画＆血液製剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Plasma Fractionation and Blood Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19548）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19548
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の血漿分画＆血液製剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

血漿分画＆血液製剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の血漿分画＆血液製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

血漿分画＆血液製剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・凝固因子、免疫グロブリン、アルブミン、その他

用途別セグメントは次のように区分されます。
・免疫学、血液学、その他

世界の血漿分画＆血液製剤市場の主要な市場プレーヤーは以下のとおりです。
・Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、血漿分画＆血液製剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な血漿分画＆血液製剤メーカーの企業概要、2019年～2022年までの血漿分画＆血液製剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な血漿分画＆血液製剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別血漿分画＆血液製剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの血漿分画＆血液製剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での血漿分画＆血液製剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および血漿分画＆血液製剤の産業チェーンを掲載しています。
・第13、14、15章では、血漿分画＆血液製剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 血漿分画＆血液製剤の概要
- 種類別分析（2017年vs2021年vs2028年）：凝固因子、免疫グロブリン、アルブミン、その他
- 用途別分析（2017年vs2021年vs2028年）：免疫学、血液学、その他
- 世界の血漿分画＆血液製剤市場規模・予測
- 世界の血漿分画＆血液製剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Takeda、CSL、Grifols、Octapharma、Kedrion、LFB Group、Biotest、BPL、RAAS、CBPO、Hualan Bio
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：凝固因子、免疫グロブリン、アルブミン、その他
・用途別分析2017年-2028年：免疫学、血液学、その他
・血漿分画＆血液製剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・血漿分画＆血液製剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・血漿分画＆血液製剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・血漿分画＆血液製剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・血漿分画＆血液製剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Plasma Fractionation and Blood Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Plasma Fractionation and Blood Product market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Immunology accounting for % of the Plasma Fractionation and Blood Product global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Coagulation Factor segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Plasma Fractionation and Blood Product include Takeda, CSL, Grifols, Octapharma, and Kedrion, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Plasma Fractionation and Blood Product market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Coagulation Factor
Immune Globulin
Albumin
Other
Market segment by Application can be divided into
Immunology
Hematology
Other
The key market players for global Plasma Fractionation and Blood Product market are listed below:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Fractionation and Blood Product product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Plasma Fractionation and Blood Product, with price, sales, revenue and global market share of Plasma Fractionation and Blood Product from 2019 to 2022.
Chapter 3, the Plasma Fractionation and Blood Product competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Fractionation and Blood Product breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Plasma Fractionation and Blood Product market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Plasma Fractionation and Blood Product.
Chapter 13, 14, and 15, to describe Plasma Fractionation and Blood Product sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Plasma Fractionation and Blood Product Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Plasma Fractionation and Blood Product Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Plasma Fractionation and Blood Product Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Global Plasma Fractionation and Blood Product Market Size & Forecast
1.4.1 Global Plasma Fractionation and Blood Product Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Plasma Fractionation and Blood Product Sales in Volume (2017-2028)
1.4.3 Global Plasma Fractionation and Blood Product Price (2017-2028)
1.5 Global Plasma Fractionation and Blood Product Production Capacity Analysis
1.5.1 Global Plasma Fractionation and Blood Product Total Production Capacity (2017-2028)
1.5.2 Global Plasma Fractionation and Blood Product Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Plasma Fractionation and Blood Product Market Drivers
1.6.2 Plasma Fractionation and Blood Product Market Restraints
1.6.3 Plasma Fractionation and Blood Product Trends Analysis
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma Fractionation and Blood Product Product and Services
2.1.4 Takeda Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma Fractionation and Blood Product Product and Services
2.2.4 CSL Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma Fractionation and Blood Product Product and Services
2.3.4 Grifols Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma Fractionation and Blood Product Product and Services
2.4.4 Octapharma Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma Fractionation and Blood Product Product and Services
2.5.4 Kedrion Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma Fractionation and Blood Product Product and Services
2.6.4 LFB Group Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma Fractionation and Blood Product Product and Services
2.7.4 Biotest Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma Fractionation and Blood Product Product and Services
2.8.4 BPL Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma Fractionation and Blood Product Product and Services
2.9.4 RAAS Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Plasma Fractionation and Blood Product Product and Services
2.10.4 CBPO Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Plasma Fractionation and Blood Product Product and Services
2.11.4 Hualan Bio Plasma Fractionation and Blood Product Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Plasma Fractionation and Blood Product Breakdown Data by Manufacturer
3.1 Global Plasma Fractionation and Blood Product Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Plasma Fractionation and Blood Product Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Plasma Fractionation and Blood Product
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma Fractionation and Blood Product Manufacturer Market Share in 2021
3.4.2 Top 6 Plasma Fractionation and Blood Product Manufacturer Market Share in 2021
3.5 Global Plasma Fractionation and Blood Product Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Plasma Fractionation and Blood Product Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Plasma Fractionation and Blood Product Market Size by Region
4.1.1 Global Plasma Fractionation and Blood Product Sales in Volume by Region (2017-2028)
4.1.2 Global Plasma Fractionation and Blood Product Revenue by Region (2017-2028)
4.2 North America Plasma Fractionation and Blood Product Revenue (2017-2028)
4.3 Europe Plasma Fractionation and Blood Product Revenue (2017-2028)
4.4 Asia-Pacific Plasma Fractionation and Blood Product Revenue (2017-2028)
4.5 South America Plasma Fractionation and Blood Product Revenue (2017-2028)
4.6 Middle East and Africa Plasma Fractionation and Blood Product Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Plasma Fractionation and Blood Product Sales in Volume by Type (2017-2028)
5.2 Global Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
5.3 Global Plasma Fractionation and Blood Product Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Plasma Fractionation and Blood Product Sales in Volume by Application (2017-2028)
6.2 Global Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
6.3 Global Plasma Fractionation and Blood Product Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Plasma Fractionation and Blood Product Sales by Type (2017-2028)
7.2 North America Plasma Fractionation and Blood Product Sales by Application (2017-2028)
7.3 North America Plasma Fractionation and Blood Product Market Size by Country
7.3.1 North America Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)
7.3.2 North America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Plasma Fractionation and Blood Product Sales by Type (2017-2028)
8.2 Europe Plasma Fractionation and Blood Product Sales by Application (2017-2028)
8.3 Europe Plasma Fractionation and Blood Product Market Size by Country
8.3.1 Europe Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)
8.3.2 Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2028)
9.2 Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2028)
9.3 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Region
9.3.1 Asia-Pacific Plasma Fractionation and Blood Product Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Plasma Fractionation and Blood Product Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Plasma Fractionation and Blood Product Sales by Type (2017-2028)
10.2 South America Plasma Fractionation and Blood Product Sales by Application (2017-2028)
10.3 South America Plasma Fractionation and Blood Product Market Size by Country
10.3.1 South America Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)
10.3.2 South America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2017-2028)
11.2 Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2017-2028)
11.3 Middle East & Africa Plasma Fractionation and Blood Product Market Size by Country
11.3.1 Middle East & Africa Plasma Fractionation and Blood Product Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Plasma Fractionation and Blood Product and Key Manufacturers
12.2 Manufacturing Costs Percentage of Plasma Fractionation and Blood Product
12.3 Plasma Fractionation and Blood Product Production Process
12.4 Plasma Fractionation and Blood Product Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Plasma Fractionation and Blood Product Typical Distributors
13.3 Plasma Fractionation and Blood Product Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Plasma Fractionation and Blood Product Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Plasma Fractionation and Blood Product Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma Fractionation and Blood Product Product and Services
Table 6. Takeda Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CSL Basic Information, Manufacturing Base and Competitors
Table 8. CSL Major Business
Table 9. CSL Plasma Fractionation and Blood Product Product and Services
Table 10. CSL Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Grifols Basic Information, Manufacturing Base and Competitors
Table 12. Grifols Major Business
Table 13. Grifols Plasma Fractionation and Blood Product Product and Services
Table 14. Grifols Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Octapharma Basic Information, Manufacturing Base and Competitors
Table 16. Octapharma Major Business
Table 17. Octapharma Plasma Fractionation and Blood Product Product and Services
Table 18. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Kedrion Basic Information, Manufacturing Base and Competitors
Table 20. Kedrion Major Business
Table 21. Kedrion Plasma Fractionation and Blood Product Product and Services
Table 22. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. LFB Group Basic Information, Manufacturing Base and Competitors
Table 24. LFB Group Major Business
Table 25. LFB Group Plasma Fractionation and Blood Product Product and Services
Table 26. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Biotest Basic Information, Manufacturing Base and Competitors
Table 28. Biotest Major Business
Table 29. Biotest Plasma Fractionation and Blood Product Product and Services
Table 30. Biotest Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. BPL Basic Information, Manufacturing Base and Competitors
Table 32. BPL Major Business
Table 33. BPL Plasma Fractionation and Blood Product Product and Services
Table 34. BPL Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. RAAS Basic Information, Manufacturing Base and Competitors
Table 36. RAAS Major Business
Table 37. RAAS Plasma Fractionation and Blood Product Product and Services
Table 38. RAAS Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. CBPO Basic Information, Manufacturing Base and Competitors
Table 40. CBPO Major Business
Table 41. CBPO Plasma Fractionation and Blood Product Product and Services
Table 42. CBPO Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 44. Hualan Bio Major Business
Table 45. Hualan Bio Plasma Fractionation and Blood Product Product and Services
Table 46. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Plasma Fractionation and Blood Product Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Plasma Fractionation and Blood Product Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Plasma Fractionation and Blood Product, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Plasma Fractionation and Blood Product Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Plasma Fractionation and Blood Product Production Site of Key Manufacturer
Table 52. Plasma Fractionation and Blood Product New Entrant and Capacity Expansion Plans
Table 53. Plasma Fractionation and Blood Product Mergers & Acquisitions in the Past Five Years
Table 54. Global Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 55. Global Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)
Table 56. Global Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 59. Global Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 60. Global Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Plasma Fractionation and Blood Product Price by Type (2017-2022) & (US$/Unit)
Table 63. Global Plasma Fractionation and Blood Product Price by Type (2023-2028) & (US$/Unit)
Table 64. Global Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 65. Global Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 66. Global Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Plasma Fractionation and Blood Product Price by Application (2017-2022) & (US$/Unit)
Table 69. Global Plasma Fractionation and Blood Product Price by Application (2023-2028) & (US$/Unit)
Table 70. North America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 71. North America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 72. North America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 75. North America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 76. North America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 77. North America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 78. Europe Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 79. Europe Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 80. Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 83. Europe Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 84. Europe Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 85. Europe Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 94. South America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 95. South America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 96. South America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 99. South America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 100. South America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 101. South America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 110. Plasma Fractionation and Blood Product Raw Material
Table 111. Key Manufacturers of Plasma Fractionation and Blood Product Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Plasma Fractionation and Blood Product Typical Distributors
Table 115. Plasma Fractionation and Blood Product Typical Customers
List of Figures
Figure 1. Plasma Fractionation and Blood Product Picture
Figure 2. Global Plasma Fractionation and Blood Product Revenue Market Share by Type in 2021
Figure 3. Coagulation Factor
Figure 4. Immune Globulin
Figure 5. Albumin
Figure 6. Other
Figure 7. Global Plasma Fractionation and Blood Product Revenue Market Share by Application in 2021
Figure 8. Immunology
Figure 9. Hematology
Figure 10. Other
Figure 11. Global Plasma Fractionation and Blood Product Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Plasma Fractionation and Blood Product Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Plasma Fractionation and Blood Product Sales (2017-2028) & (K Units)
Figure 14. Global Plasma Fractionation and Blood Product Price (2017-2028) & (US$/Unit)
Figure 15. Global Plasma Fractionation and Blood Product Production Capacity (2017-2028) & (K Units)
Figure 16. Global Plasma Fractionation and Blood Product Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Plasma Fractionation and Blood Product Market Drivers
Figure 18. Plasma Fractionation and Blood Product Market Restraints
Figure 19. Plasma Fractionation and Blood Product Market Trends
Figure 20. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturer in 2021
Figure 21. Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturer in 2021
Figure 22. Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Plasma Fractionation and Blood Product Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Plasma Fractionation and Blood Product Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)
Figure 26. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2028)
Figure 27. North America Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)
Figure 28. Europe Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)
Figure 30. South America Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Plasma Fractionation and Blood Product Revenue (2017-2028) & (USD Million)
Figure 32. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 33. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
Figure 34. Global Plasma Fractionation and Blood Product Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 36. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
Figure 37. Global Plasma Fractionation and Blood Product Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 39. North America Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 40. North America Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2028)
Figure 41. North America Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2028)
Figure 42. United States Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 46. Europe Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 47. Europe Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2028)
Figure 48. Europe Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2028)
Figure 49. Germany Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2028)
Figure 58. China Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 65. South America Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 66. South America Plasma Fractionation and Blood Product Sales Market Share by Country (2017-2028)
Figure 67. South America Plasma Fractionation and Blood Product Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Plasma Fractionation and Blood Product Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Plasma Fractionation and Blood Product in 2021
Figure 79. Manufacturing Process Analysis of Plasma Fractionation and Blood Product
Figure 80. Plasma Fractionation and Blood Product Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の血漿分画装置市場2022年：市場規模予測（～2028年）
  • 世界の血漿分画製品市場2022年：市場規模予測（～2028年）
  • ヒト血漿分画製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他
  • 血液分画装置のグローバル市場展望 2023年-2029年：ラボスケール、生産ライン
  • 全血・血漿・血清粘度計のグローバル市場展望 2023年-2029年：回転粘度計、キャピラリー粘度計
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19548 )"世界の血漿分画＆血液製剤市場2022年：市場規模予測（～2028年）" (英文：Global Plasma Fractionation and Blood Product Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。